PATENT CLAIM ANALYSIS

Application Number: 15905203
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "021500"]

Abstract:
A method and a pharmaceutical composition for increasing wound healing in an individual in need thereof, the method comprising administering an angiopoietin like 4 (ANGPTL4) polypeptide or a therapeutically active fragment thereof.

Claim (Index 8):
The pharmaceutical composition of  claim 1 , wherein the therapeutically active fragment of the ANGPTL4 comprising the C-terminal region of the ANGPTL4 polypeptide or functional fragment thereof comprises:\n (i) the amino acid sequence set forth in SEQ ID NO:2; or (ii) an amino acid sequence having at least 60, at least 70, at least 80, at least 85, at least 90, at least 95, at least 97, at least 98 or at least 99% sequence identity with the amino acid sequence set forth in SEQ ID NO:2 over its entire length; or (iii) an amino acid sequence having at least 70, at least 80, at least 85, at least 90, at least 95, at least 97, at least 98 or at least 99% sequence homology with the amino acid sequence set forth in SEQ ID NO: 2 over its entire length.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.16129
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14415399', '10853505', '11284430', '14590397', '13590113']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7325509571472142
- 35 USC 102 Novelty (BERT): 0.5741371711167007
- Combined Prediction Score: 0.7167095785441628
- Mean Citation Score: 344.013586
- Max Citation Score: 582.4230299999998
- Similarity Product: 345.4832555711638

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test